Suplatast tosilate

Drug Profile

Suplatast tosilate

Alternative Names: IPD; IPD 1151T; Suplatast tosylate; YM 672

Latest Information Update: 24 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Taiho Pharmaceutical
  • Developer Senju Pharmaceutical; Taiho Pharmaceutical
  • Class Antiallergics; Antiasthmatics; Antihistamines; Arylsulfonates
  • Mechanism of Action Cytokine inhibitors; Histamine release inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Allergic rhinitis; Asthma; Atopic dermatitis
  • No development reported Prostatitis; Pulmonary eosinophilia
  • Discontinued Interstitial cystitis

Most Recent Events

  • 06 Nov 2007 Discontinued - Phase-II for Interstitial cystitis in Europe (PO)
  • 06 Nov 2007 Discontinued - Phase-II for Interstitial cystitis in USA (PO)
  • 06 Nov 2007 Discontinued - Phase-III for Interstitial cystitis in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top